Electronic Pharmaceutical Prescriptions

Research conducted by: RAND Health

All Items (19)

REPORT

Focus on Health Information Technology — Mar 30, 2012

For nearly a decade, RAND researchers have studied how health information technology (HIT) stands to change health care.

JOURNAL ARTICLE

Early Adopters of Electronic Prescribing Struggle to Make Meaningful Use of Formulary Checks and Medication History Documentation — Jan 1, 2012

In offices where e-prescribing was implemented, prescribers used information about formularies and drug benefits, but missing information reduced confidence in these resources and led to paper-based workarounds.

JOURNAL ARTICLE

High-priority Drug -- Drug Interactions for Use in Electronic Health Records — Jan 1, 2012

A panel of experts highlighted the complexity of issues surrounding development and implementation of a set of high-severity, clinically significant drug–drug interactions (DDIs) for use in electronic health records (EHRs).

JOURNAL ARTICLE

Meaningful Use of Electronic Prescribing in 5 Exemplar Primary Care Practices — Oct 1, 2011

Widespread implementation and effective use of e-prescribing in ambulatory care will require practice transformation efforts that focus on work process redesign while being attentive to effects on patient and pharmacy involvement in prescribing.

JOURNAL ARTICLE

Today's 'Meaningful Use' Standard for Medication Orders by Hospitals May Save Few Lives; Later Stages May Do More — Oct 1, 2011

Current federal standards for hospital "meaningful use" of health information technology--which requires electronic medication orders for 30 percent of eligible patients--are probably too low to reduce deaths from heart failure and heart attack among hospitalized Medicare beneficiaries.

REPORT

How Should Drugs Be Identified in Electronic Prescribing Systems? — Jul 20, 2011

The set of computer-interpretable identifiers currently used in electronic prescribing does not support the specific needs of prescribers and pharmacists. RxNorm, a rigorously derived system of drug identifiers that more accurately reflect the prescriber's intent, has potential to improve e-prescribing transactions.

RESEARCH BRIEF

How Should Drugs be Identified in Electronic Prescribing Systems? — Jul 20, 2011

RxNorm has potential to improve how medications are represented in e-prescribing transactions.

RESEARCH BRIEF

Will Adoption of Electronic Health Records Improve Quality in U.S. Hospitals? — Feb 9, 2011

Shares findings on the potential effects of electronic health records (EHRs) on health care quality, based on analysis of extensive data from 2003 and 2006 on EHR adoption, hospital characteristics, and hospital quality in nearly 2,100 hospitals.

JOURNAL ARTICLE

Evaluation of the NCPDP Structured and Codified Sig Format for E-Prescriptions — Jan 1, 2011

This paper reports an assessment of how well the structure and code sets specified in the National Council for Prescription Drug Programs Structured and Codified Sig Format represent ambulatory electronic prescriptions.

JOURNAL ARTICLE

Patient Protection and Affordable Care Act: Laying the Infrastructure for National Health Reform — Jun 1, 2010

This article discusses the range of health information technology initiatives included in the 2009 economic stimulus legislation that collectively are known as the Health Information Technology for Economic and Clinical Health (HITECH) initiative; these include proposed regulations on "meaningful use" of information technology and standards; funding of regional extension centers; and support for the development and use of clinical…

JOURNAL ARTICLE

Evaluation of RxNorm for Representing Ambulatory Prescriptions — Jan 1, 2010

RxNorm provides concepts covering nearly all ambulatory e-prescriptions but could be improved by making it possible to select the most-specific concepts within broader concepts.

JOURNAL ARTICLE

Perceptions of Standards-Based Electronic Prescribing Systems as Implemented in Outpatient Primary Care: A Physician Survey — Jul 15, 2009

Compare the experiences of e-prescribing users and non-users regarding prescription safety and workload and to assess the use of information from two e-prescribing standards (for medication history and formulary and benefit information), as

JOURNAL ARTICLE

Interoperable Electronic Prescribing in the United States: A Progress Report — Mar 15, 2009

Although the vast majority of U.S. physicians still handwrite prescriptions, adoption of electronic prescribing is slowly growing. Major barriers to adoption remain, including the inability to electronically submit prescriptions for controlled substances and confusion about standards for data exchange. Federal and state governments and private insurers are using payment and policy incentives to boost e-prescribing because they still…

JOURNAL ARTICLE

Variation in Electronic Prescribing Implementation Among Twelve Ambulatory Practices — Apr 1, 2008

Describes practice characteristics associated with implementation and use of e-prescribing in ambulatory settings. Successful practices exhibited greater familiarity with capabilities and had more modest expectations about benefits of e-prescribing.

NEWS RELEASE

RAND to Lead Research Team Probing Adequacy of Standards for Electronic Drug Prescriptions — Jan 18, 2006

RAND news release: RAND to Lead Research Team Probing Adequacy of Standards for Electronic Drug Prescriptions

RESEARCH BRIEF

Electronic Prescribing Systems: Making It Safer to Take Your Medicine? — Nov 25, 2005

RAND Health researchers convened an expert panel that created a set of 60 recommendations for electronic prescribing systems.

JOURNAL ARTICLE

A Conceptual Framework for Evaluating Outpatient Electronic Prescribing Systems Based on Their Functional Capabilities — Jan 1, 2004

More research is needed into the effects of specific e-prescribing functional alternatives.

JOURNAL ARTICLE

Predicting Costs of Care Using a Pharmacy-Based Measure Risk Adjustment in a Veteran Population — Jan 1, 2003

Condition Categories model performs best (R2 = 0.45) among concurrent cost models, followed by ADG (0.31), RxRisk-V (0.20), and age/sex model (0.01).

My RAND ?

Saved Items

Recommended